A remarkable year for the Burnet Institute

Burnet Institute

27 May, 2014

Professor Brendan Crabb launches the 2013 Annual Financial Report.

Burnet Institute Director and CEO, Professor Brendan Crabb has formally launched the Annual Financial Report which highlights the Institute’s most significant achievements for 2013.

Professor Crabb said it was an amazing year for the Institute, setting a new research performance record with 200 peer-reviewed publications, exceeding the previous year by 10 per cent.

“This is a great reflection on the productivity and quality of the Institute’s research programs both in the laboratory and in the field,” Professor Crabb said.

“While we continued to focus on our core activities, we also implemented a number of new strategic initiatives, which opened up new opportunities for the Institute across the region.”

Professor Crabb highlighted the progress of both the Visitect® CD4 point-of-care test which began feasibility trials in PNG, India and Africa, and the hepatitis C vaccine initiative which is moving towards stage one clinical trials.

“We received a Chinese Government 321 grant which led to the establishment of Nanjing BioPoint Diagnostics to develop a rapid point-of-care liver function test, a hugely needed tool for China and the world.”

The Institute’s Healthy Mothers, Healthy Babies program in Papua New Guinea, commenced during 2013. The $10 million research program will identify the most effective way of reducing the numbers of women and children who die as a result of childbirth.

The Institute also significantly expanded its tuberculosis (TB) research and public health programs in response to the emergence of multidrug-resistant TB in the region, a major public health priority.

Professor Crabb thanked the staff, board and the Institute’s supporters for their outstanding contributions during 2013 and looked forward to another successful and productive year.

CLICK HERE to download the 2013 Annual Financial Report.

Staff Member


Contact Details

For more information in relation to this news article, please contact:

Professor Brendan Crabb AC

Director and CEO; Co-Head Malaria Research Laboratory; Chair, Victorian Chapter of the Association of Australian Medical Research Institutes (AAMRI)




Subscribe to News

Subscribe to receive our latest news: